{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:48:06Z","timestamp":1777085286896,"version":"3.51.4"},"reference-count":23,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Less than 5% of patients with a plasma cell dyscrasia present with a single bone (SBP) or extramedullary plasmacytoma (EMP) without evidence of systemic disease (normocalcemia, absence of anemia, preservation of uninvolved immunoglobulins, or renal disease attributable to myeloma). Diagnosis requires biopsy confirmation of a monoclonal plasma cell infiltrate from a single site. The treatment of choice for both entities is radiotherapy given with curative intent (&gt; 4000 cGy) resulting in long term disease-free survival in approximately 30% of patients with SBP and 65% of patients with EMP.<\/jats:p>","DOI":"10.1182\/asheducation-2005.1.373","type":"journal-article","created":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T20:29:34Z","timestamp":1132691374000},"page":"373-376","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":95,"title":["Solitary Bone and Extramedullary Plasmacytoma"],"prefix":"10.1182","volume":"2005","author":[{"given":"Donna M.","family":"Weber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2019111702360444400_R1","doi-asserted-by":"crossref","unstructured":"Moulopoulos LA, Dimopoulos MA, Weber D, et al. Magnetic resonance imaging in the staging of solitary plasmacytoma of bone. J Clin Oncol. 1993;11:1311\u20131315.","DOI":"10.1200\/JCO.1993.11.7.1311"},{"key":"2019111702360444400_R2","doi-asserted-by":"crossref","unstructured":"Liebross RH, Ha CS, Cox JD, et al. Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998;41:1063\u20131067.","DOI":"10.1016\/S0360-3016(98)00186-2"},{"key":"2019111702360444400_R3","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol. 2002;3:255\u2013259.","DOI":"10.1007\/s11864-002-0015-2"},{"key":"2019111702360444400_R4","doi-asserted-by":"crossref","unstructured":"Dimopoulos MA, Moulopoulos LA, Maniatis A, et al. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96:2037\u20132044.","DOI":"10.1182\/blood.V96.6.2037"},{"key":"2019111702360444400_R5","doi-asserted-by":"crossref","unstructured":"Guidelines Working Group of the UK Myeloma Forum (UKMF). Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004;124:717\u2013726.","DOI":"10.1111\/j.1365-2141.2004.04834.x"},{"key":"2019111702360444400_R6","doi-asserted-by":"crossref","unstructured":"Wilder RB, Ha CS, Cox JD, et al. Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone. Cancer. 2001;94:1532\u20131537.","DOI":"10.1002\/cncr.10366"},{"key":"2019111702360444400_R7","doi-asserted-by":"crossref","unstructured":"Drayson MT, Tang LX, Drew R, et al. Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma. Blood. 2001;97:2000\u20132902.","DOI":"10.1182\/blood.V97.9.2900"},{"key":"2019111702360444400_R8","doi-asserted-by":"crossref","unstructured":"Tsang RW, Gospodarowiez MK, Pintille M, et al. Solitary plasmacytoma treated with radio therapy: Impact of tumor size on outcome. Int J Radiat Oncol Biol Phys. 2001;50:113\u2013120.","DOI":"10.1016\/S0360-3016(00)01572-8"},{"key":"2019111702360444400_R9","doi-asserted-by":"crossref","unstructured":"Mendenhall CM, Thar TL, Million RR. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1980;6:1497\u20131501.","DOI":"10.1016\/0360-3016(80)90006-1"},{"key":"2019111702360444400_R10","doi-asserted-by":"crossref","unstructured":"Frassica D, Frassica FJ, Schray MF, et al. Solitary plasmacytoma of bone: Mayo clinic experience. Int J Radiat Oncol Biol Phys. 1989;16:43\u201348.","DOI":"10.1016\/0360-3016(89)90008-4"},{"key":"2019111702360444400_R11","doi-asserted-by":"crossref","unstructured":"Fang Z, Yi X, Zhu T. Anterior approach to the second thoracic vertebral body for surgical treatment (vertebrectomy, bone grafting and titanium alloy plate fixation). Int J Clin Oncol. 2001;6:205\u2013208.","DOI":"10.1007\/PL00012106"},{"key":"2019111702360444400_R12","doi-asserted-by":"crossref","unstructured":"Jantunen E, Koivunen E, Putkonen M, et al. Autologous stem cell transplantation in patients with high risk plasmacytoma. Eur J Haematol. 2005;74:402\u2013406.","DOI":"10.1111\/j.1600-0609.2004.00404.x"},{"key":"2019111702360444400_R13","doi-asserted-by":"crossref","unstructured":"Bataille R, Sany J. Solitary myeloma: Clinical and prognostic features of a review of 114 cases. Cancer. 1981;48:845\u2013851","DOI":"10.1002\/1097-0142(19810801)48:3<845::AID-CNCR2820480330>3.0.CO;2-E"},{"key":"2019111702360444400_R14","doi-asserted-by":"crossref","unstructured":"Holland J, Trenkner DA, Wasserman TH, et al. Plasmacytoma. Treatment results and conversion to myeloma. Cancer. 1992;69:1513\u20131517.","DOI":"10.1002\/1097-0142(19920315)69:6<1513::AID-CNCR2820690633>3.0.CO;2-X"},{"key":"2019111702360444400_R15","doi-asserted-by":"crossref","unstructured":"Bolek TW, Marcus RB, Mendenhall NP. Solitary plasmacytoma of bone and soft tissue. Int J Radiat Oncol Biol Phys. 1996;36:329\u2013333.","DOI":"10.1016\/S0360-3016(96)00334-3"},{"key":"2019111702360444400_R16","doi-asserted-by":"crossref","unstructured":"Chao MW, Gibbs P, Wirth A, et al. Radiotherapy in the management of solitary extramedullary plasmacytoma. Intern Med J. 2005;35:211\u2013215.","DOI":"10.1111\/j.1445-5994.2005.00804.x"},{"key":"2019111702360444400_R17","doi-asserted-by":"crossref","unstructured":"Liebross RH, Ita CS, Cox JD, et al. Clinical Course of extramedullary plasmacytoma. Radiother Oncol. 1999;52:245\u2013249.","DOI":"10.1016\/S0167-8140(99)00114-0"},{"key":"2019111702360444400_R18","doi-asserted-by":"crossref","unstructured":"Susnerwala SS, Shanks JH, Banerjee SS, et al. Extramedullary plasmacytoma of the head and neck region: clinico-pathological correlation in 25 cases. Br J Cancer. 1997;75:921\u2013927.","DOI":"10.1038\/bjc.1997.162"},{"key":"2019111702360444400_R19","doi-asserted-by":"crossref","unstructured":"Wax MK, Yun KN, Omar RA. Extramedullary plasmacytomas of the head and neck. Otolaryngol Head Neck Surg. 1993;109:877\u2013885.","DOI":"10.1177\/019459989310900517"},{"key":"2019111702360444400_R20","unstructured":"Hu K and Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology. 2000;14:101\u2013111."},{"key":"2019111702360444400_R21","doi-asserted-by":"crossref","unstructured":"Alexiou C, Kau RJ, Dietzfelbinger H, et al. Extramedullary plasmacytoma: Tumor occurrence and therapeutic concepts. Cancer. 1999;85:2305\u20132314.","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3"},{"key":"2019111702360444400_R22","doi-asserted-by":"crossref","unstructured":"Galieni P, Cavo M, Avvisati G, et al. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol. 1995;6:687\u2013691.","DOI":"10.1093\/oxfordjournals.annonc.a059285"},{"key":"2019111702360444400_R23","doi-asserted-by":"crossref","unstructured":"Brinch L, Hannisdal E, Foss A, et al. Extramedullary plasmacytomas and solitary plasma cell tumours of bone. Eur J Haematol. 1990;44:131\u2013134.","DOI":"10.1111\/j.1600-0609.1990.tb00364.x"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/373\/645271\/373.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2005\/1\/373\/645271\/373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T02:36:16Z","timestamp":1573958176000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2005\/1\/373\/19324\/Solitary-Bone-and-Extramedullary-Plasmacytoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2005.1.373","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,1]]}}}